Mednax Inc (MD)-Financial and Strategic SWOT Analysis Review

Mednax Inc (MD)-Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH83314FSA
  • |
  • Pages: 52
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Mednax Inc (MD)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Mednax Inc (Mednax) is a national medical group company, which operates a network of physician service providers. The company offers a wide range of neonatal, anesthesia, maternal-fetal, pediatric physician and subspecialty services. Its network includes other pediatric subspecialists comprising physicians providing pediatric intensive care; pediatric cardiology care, hospital-based pediatric care and pediatric surgical care. Mednax also provides other services related to healthcare facilities and physicians, through complementary businesses, consisting of a revenue cycle management company and a consulting services company. The company through its affiliated professional corporations has presence in several states across the US and in Puerto Rico. Mednax is headquartered in Sunrise, Florida, the US.

Mednax Inc Key Recent Developments

Apr 20,2017: MEDNAX Previews 2017 First Quarter Results

Feb 07,2017: MEDNAX Reports Fourth Quarter GAAP EPS of $0.84; Adjusted EPS of $1.00

Nov 07,2016: MEDNAX Announces Divisional Leadership Changes

Oct 27,2016: MEDNAX Reports Third Quarter GAAP EPS of $1.04; Adjusted EPS of $1.09

Jul 28,2016: MEDNAX Reports Second Quarter GAAP EPS of $0.89; Adjusted EPS of $1.03

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Mednax Inc-Key Facts 5

Mednax Inc-Key Employees 6

Mednax Inc-Key Employee Biographies 8

Mednax Inc-Major Products and Services 9

Mednax Inc-History 10

Mednax Inc-Company Statement 14

Mednax Inc-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 18

Mednax Inc-Business Description 18

Mednax Inc-SWOT Analysis 19

SWOT Analysis-Overview 19

Mednax Inc-Strengths 19

Mednax Inc-Weaknesses 20

Mednax Inc-Opportunities 21

Mednax Inc-Threats 22

Mednax Inc-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Mednax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Mednax Inc, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Apr 20, 2017: MEDNAX Previews 2017 First Quarter Results 34

Feb 07, 2017: MEDNAX Reports Fourth Quarter GAAP EPS of $0.84; Adjusted EPS of $1.00 36

Nov 07, 2016: MEDNAX Announces Divisional Leadership Changes 38

Oct 27, 2016: MEDNAX Reports Third Quarter GAAP EPS of $1.04; Adjusted EPS of $1.09 39

Jul 28, 2016: MEDNAX Reports Second Quarter GAAP EPS of $0.89; Adjusted EPS of $1.03 41

Jul 12, 2016: MEDNAX to Exhibit at the 24th Annual Health Forum and the American Hospital Association Leadership Summit 43

Apr 28, 2016: MEDNAX Reports First Quarter Adjusted EPS of $0.87; GAAP EPS of $0.73 44

Feb 04, 2016: MEDNAX Reports Double-Digit Fourth Quarter 2015 Revenue and EPS Growth 46

Section 6-Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52

List of Figures

Mednax Inc, Performance Chart (2012-2016) 28

Mednax Inc, Ratio Charts 30

Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Mednax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 32

List of Tables

Mednax Inc, Key Facts 5

Mednax Inc, Key Employees 6

Mednax Inc, Key Employee Biographies 8

Mednax Inc, Major Products and Services 9

Mednax Inc, History 10

Mednax Inc, Subsidiaries 15

Mednax Inc, Key Competitors 23

Mednax Inc, Ratios based on current share price 24

Mednax Inc, Annual Ratios 25

Mednax Inc, Annual Ratios (Cont...1) 26

Mednax Inc, Annual Ratios (Cont...2) 27

Mednax Inc, Interim Ratios 29

Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Mednax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Mednax Inc, Recent Deals Summary 33

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

IPC Healthcare Inc Healthways Inc Community Health Systems Inc

Mednax Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8625
Site License
USD 250 INR 17250
Corporate User License
USD 375 INR 25875



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]